Valentine’s Day has come and gone, and the weeks that follow are busy days for infectious disease doctors like me. Roses, chocolates, and hot dates give ...
The results came from a survey of nearly 8,000 US residents, aged 18 to 65, who had been infected with an STD at least once.
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the pivotal Phase III study (FENhance 1) of fenebrutinib in RMS met its primary endpoint, showing clinically ...
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results